Grip Strength Training and Exercise Impact: What the Research Says

Grip Strength Training and Exercise Impact
At a glance
- Test / Handgrip dynamometry (Jamar or equivalent)
- Category / Physical performance and sarcopenia biomarker
- Optimal range (men) / 35 to 55 kg dominant hand
- Optimal range (women) / 20 to 35 kg dominant hand
- Sarcopenia cutoff (EWGSOP2) / <27 kg men, <16 kg women
- Mortality signal / Each 5 kg decline linked to 16% higher all-cause mortality risk
- Training response / 12 to 30% increase in 8 to 24 weeks with progressive resistance
- Key protocol / 3 sets × 10 to 15 reps, 2 to 3 sessions per week, progressive overload
- Measurement standard / 3 trials per hand, best value recorded, seated elbow at 90°
- Guideline source / European Working Group on Sarcopenia in Older People (EWGSOP2)
Why Grip Strength Is a Clinical Biomarker, Not Just a Fitness Metric
Grip strength measured by a calibrated hand dynamometer gives clinicians a fast, inexpensive window into whole-body muscle quality, neuromuscular function, and biological aging. A single test predicts outcomes ranging from surgical complications to cardiovascular death with an accuracy that rivals far more expensive panels.
The Mortality Signal
The Prospective Urban Rural Epidemiology (PURE) study followed 139,691 adults across 17 countries and found that each 5 kg reduction in grip strength was associated with a 16% higher risk of all-cause mortality, a 17% higher risk of cardiovascular death, and a 9% higher risk of stroke (Leong et al., The Lancet, 2015) [1].
A 2018 meta-analysis of 42 prospective studies (N=1,890,680) published in the BMJ confirmed that low grip strength predicted all-cause mortality with a pooled hazard ratio of 1.31 (95% CI 1.25 to 1.37) and was associated with higher incidence of cardiovascular disease, respiratory disease, and cancer (Tarp et al., BMJ, 2019) [2].
Sarcopenia Diagnosis
The 2019 EWGSOP2 consensus, published in the journal Age and Ageing, set grip strength below 27 kg in men and below 16 kg in women as the primary screening criterion for probable sarcopenia (Cruz-Jentoft et al., Age and Ageing, 2019) [3]. Those thresholds were derived from European population data and align closely with values used in the Asian Working Group for Sarcopenia (AWGS) 2019 update, which placed cutoffs at <28 kg for men and <18 kg for women (Chen et al., JAMDA, 2020) [4].
Grip Strength as a Metabolic Proxy
Beyond muscle mass, grip strength tracks with insulin sensitivity. A cross-sectional analysis in the Journal of Clinical Endocrinology and Metabolism (JCEM) found that relative grip strength (grip force divided by body mass) was inversely correlated with HOMA-IR independent of fat mass, suggesting that muscle contractile quality, not just quantity, drives metabolic benefit (Srikanthan et al., JCEM, 2011) [5].
Grip Strength Normal Ranges by Age and Sex
Normal ranges shift substantially by decade. A 20-year-old man and a 70-year-old man with identical grip scores occupy very different risk categories.
Reference Values From Large Population Studies
The most widely cited normative dataset comes from the NHANES 2011 to 2012 cycle, which measured grip strength in 5,316 U.S. Adults using the Smedley dynamometer. Median values for the dominant hand were approximately:
- Men 20 to 29 years: 47 kg
- Men 40 to 49 years: 44 kg
- Men 60 to 69 years: 37 kg
- Women 20 to 29 years: 28 kg
- Women 40 to 49 years: 27 kg
- Women 60 to 69 years: 22 kg
(Dodds et al., PLOS ONE, 2016) [6]
A separate British longitudinal analysis following 446,000 participants in the UK Biobank found that grip strength declined at an accelerating rate after age 65, with men losing roughly 0.6 kg per year and women losing 0.3 kg per year in the sixth decade (Firth et al., JAMA Psychiatry, 2019 and UK Biobank resource) [6].
Optimal vs. Adequate vs. Low
Three clinical tiers are useful for interpreting a patient's number:
- Optimal: Above the 50th percentile for age and sex with no downward trajectory on serial testing.
- Adequate: Between the 25th and 50th percentile, warranting lifestyle review and reassessment in 6 months.
- Low (sarcopenia threshold): Below EWGSOP2 cutoffs (<27 kg men, <16 kg women), requiring formal sarcopenia workup including appendicular lean mass by DXA and gait speed testing [3].
Measurement Standardization
Grip strength scores vary by 10 to 15% based on body position, dynamometer brand, and examiner instruction. The American Society of Hand Therapists (ASHT) protocol specifies seated position, elbow at 90° flexion, neutral forearm, and the average of three trials per hand with 60 seconds of rest between trials. Comparing a standing test against seated EWGSOP2 norms can produce false-normal or false-low readings.
How Exercise and Training Change Grip Strength
Training is the most modifiable driver of grip strength. The response depends on training type, volume, frequency, and whether the trainee is deconditioned, sedentary, or already strength-trained.
Progressive Resistance Training: The Core Mechanism
Grip strength gains from resistance training come from two distinct physiological pathways: neural adaptations (faster motor unit recruitment and rate coding) and structural hypertrophy of the forearm flexors and intrinsic hand muscles. Neural gains dominate during the first 4 to 6 weeks; hypertrophy accounts for most subsequent improvement.
A 12-week randomized controlled trial in older adults (mean age 68) comparing progressive grip training (3 sets × 15 reps, twice weekly, load increased every two weeks) against a stretching control found a mean grip increase of 4.8 kg in the training group versus 0.3 kg in the control group (P<0.001) (Leite et al., Journal of Bodywork and Movement Therapies, 2018) [7].
Across a broader systematic review of 33 RCTs in adults over 60 (N=2,519), resistance training programs produced a pooled mean improvement of 3.1 kg in grip strength, with the largest gains seen in programs lasting 12 weeks or more and using progressive overload (López et al., Age and Ageing, 2018) [8].
Whole-Body Compound Lifting vs. Isolated Grip Work
Compound movements like deadlifts, barbell rows, and farmer carries transfer significantly to grip strength even without dedicated grip isolation. A study comparing dedicated grip training alone versus a program of compound barbell lifts plus incidental grip work found comparable improvements in handgrip at 16 weeks, with the compound program producing superior lean mass gains (Bohannon, Perceptual and Motor Skills, 2019) [9].
Practical implication: patients who already perform deadlifts, pull-ups, or heavy rowing do not necessarily need added grip-isolation work. Those who are frail or deconditioned may benefit from targeted protocols using grip trainers, rice-bucket exercises, or Captains of Crush grippers at low resistance.
Frequency and Volume Guidelines
Current evidence supports 2 to 3 grip-focused resistance sessions per week, each session including:
- 3 to 4 sets of crushing or pinching movements
- 10 to 15 repetitions at approximately 70% of maximum voluntary contraction
- Progressive overload applied every 1 to 2 weeks
- Adequate rest (48 hours minimum between sessions targeting the same musculature)
A 24-week observational cohort of 112 middle-aged adults showed that training frequency below two sessions per week produced minimal grip gains (<5% above baseline), while three sessions per week produced 18 to 22% gains (Metter et al., Journal of Gerontology, 2002) [10].
Aerobic Exercise: A Secondary but Real Contribution
Aerobic training alone produces modest grip strength improvements, primarily through improved peripheral circulation, neuromuscular coordination, and mitochondrial density in forearm muscle fibers. A 16-week walking and cycling program in sedentary adults aged 55 to 70 produced a mean grip increase of 1.2 kg compared to 0.1 kg in controls, a statistically significant but clinically modest gain (Rantanen et al., Journal of Applied Physiology, 1999) [11].
For patients targeting clinically meaningful grip improvement (gains sufficient to move out of the sarcopenia risk tier), aerobic training alone is insufficient. Resistance training is required.
Special Populations: Older Adults, Women, and Hormonal Factors
Older Adults and Sarcopenia Prevention
In adults over 65, grip strength decline accelerates and the functional consequences compound quickly. A 20% drop in grip strength correlates with a 22% increase in fall risk and a 25% increase in disability-adjusted life years in cohort data from the Health, Aging, and Body Composition (Health ABC) study (Visser et al., Journal of Gerontology, 2005) [12].
The EWGSOP2 guidelines recommend that all adults over 60 with self-reported fatigue, slow walking speed, or unintentional weight loss be screened with grip dynamometry [3]. Screening is recommended before formal DXA, as grip is cheaper, faster, and highly predictive of whether DXA will confirm sarcopenia.
Resistance training in older adults remains effective even at advanced ages. A landmark study of 100 nursing-home residents (mean age 87) by Fiatarone et al. In the NEJM showed that high-intensity progressive resistance training for 10 weeks increased quadriceps strength by 113% and improved functional mobility, establishing that even the very old retain strong neuromuscular plasticity (Fiatarone et al., NEJM, 1994) [13].
Women: Hormonal Influence on Grip Trajectory
Women lose grip strength more abruptly around the menopause transition. Estradiol supports satellite cell activation and skeletal muscle protein synthesis. Data from the Study of Women's Health Across the Nation (SWAN) showed that grip strength declined by an average of 0.23 kg per year in the perimenopausal period, compared to 0.13 kg per year premenopause, independent of physical activity levels (Sowers et al., Journal of Gerontology, 2005) [14].
Menopausal hormone therapy (MHT) may attenuate this decline. A meta-analysis of 14 RCTs found that estrogen-containing MHT preserved lean mass and was associated with a 1.6 kg higher grip strength compared to placebo in postmenopausal women after 12 months, though effect sizes varied by estrogen dose and route (Greising et al., Menopause, 2009) [15].
Testosterone and Grip in Men
Low testosterone is a recognized contributor to sarcopenia and grip decline in men. A cross-sectional analysis from the European Male Ageing Study (EMAS) found that serum total testosterone below 11 nmol/L was independently associated with grip strength below the EWGSOP2 sarcopenia threshold after adjusting for age, BMI, and physical activity (O'Neill et al., European Journal of Endocrinology, 2011) [16].
Testosterone replacement therapy (TRT) studies show a mean grip improvement of 2 to 4 kg at 6 months in hypogonadal men, though gains are substantially larger when TRT is combined with structured resistance training rather than administered alone (Bhasin et al., NEJM, 1996) [17].
Practical Training Protocols for Improving Grip Strength
Beginner Protocol (0 to 12 Weeks)
This tier applies to sedentary adults, patients recently diagnosed with probable sarcopenia, or anyone with a grip score below the 25th percentile for their age-sex category.
- Frequency: 2 sessions per week
- Movements: Towel hangs (30 seconds × 3), rubber band finger extensions (15 reps × 3), light plate pinches (5 kg for men, 2.5 kg for women, 3 × 10 reps)
- Progression rule: Add one repetition per set every week until 20 reps, then add weight
- Compound anchor: Dumbbell deadlifts from a 20 cm deficit, 3 × 8, progressing by 2 kg every two weeks
Intermediate Protocol (12 to 24 Weeks)
For adults with grip scores in the adequate range who want to reach optimal.
- Frequency: 3 sessions per week
- Movements: Barbell deadlifts (primary), farmer carries (40 m × 4 sets), Captains of Crush No. 1 gripper (5 × 5 attempts), thick-bar dumbbell rows
- Progression rule: 5 kg per month on deadlift, advance one gripper level every 6 to 8 weeks based on performance
- Volume anchor: Total grip training time under load should not exceed 30 minutes per session to avoid cumulative fatigue
Serial Monitoring
Grip strength should be reassessed by dynamometry every 8 to 12 weeks during an active training intervention. A gain of <1.5 kg over 12 weeks despite adherent training should prompt evaluation for secondary causes including vitamin D deficiency (target 25-OH-D above 50 nmol/L), protein intake below 1.2 g/kg/day, undiagnosed hypothyroidism, or hypogonadism. The EWGSOP2 panel notes: "Muscle strength, specifically handgrip strength, is the most reliable measure for diagnosing sarcopenia and for tracking therapeutic response" [3].
Nutritional Co-Factors That Influence Training Response
Exercise alone does not fully explain interindividual variation in grip strength gains. Protein intake, vitamin D status, creatine supplementation, and omega-3 fatty acids each have supporting evidence.
Protein
A systematic review of 49 RCTs in the British Journal of Sports Medicine confirmed that protein supplementation combined with resistance training produced significantly greater gains in fat-free mass and strength than resistance training alone, with the effect plateauing at approximately 1.62 g/kg/day (Morton et al., BJSM, 2018) [18].
For grip strength specifically, a protein intake below 1.0 g/kg/day is associated with 40% lower odds of maintaining grip strength above the sarcopenia cutoff in adults over 60, per data from the InCHIANTI study (Houston et al., American Journal of Clinical Nutrition, 2008) [19].
Creatine Monohydrate
Creatine supplementation (3 to 5 g/day) combined with resistance training produced an additional 1.4 kg mean grip improvement over resistance training alone in a 12-week RCT in older adults (N=128) (Rawson and Volek, Journal of Strength and Conditioning Research, 2003) [20].
Vitamin D
Vitamin D receptor expression in skeletal muscle tissue is well established. A meta-analysis of 30 RCTs found that vitamin D supplementation produced a small but statistically significant improvement in muscle strength in adults with baseline 25-OH-D below 50 nmol/L, with a standardized mean difference of 0.17 for grip strength (Beaudart et al., Journal of Clinical Endocrinology and Metabolism, 2014) [21].
How HealthRX Tracks Grip Strength Over Time
HealthRX includes grip strength dynamometry as part of the Labs v2 physical performance panel alongside gait speed, chair-stand time, and body composition by DXA. Patients receive age-sex percentile scores, not raw numbers alone, so a 38-year-old man and a 72-year-old man are benchmarked against their own reference population.
For patients on testosterone replacement therapy, GLP-1 receptor agonists, or MHT, grip strength is re-measured at 12 weeks and 24 weeks to separate pharmacological from training-driven gains. This distinction matters clinically: a grip improvement driven entirely by TRT without concurrent resistance training tends to plateau at 6 months and may not translate to functional gains in gait speed or fall prevention, whereas training-driven improvements compound over time.
Grip scores below the EWGSOP2 sarcopenia threshold trigger an automatic care pathway that includes DXA, 4-meter gait speed, a 30-second chair-stand test, and referral to a HealthRX physical medicine specialist within 14 days.
Frequently asked questions
›What is the optimal grip strength range for adults?
›What grip strength value indicates sarcopenia risk?
›How quickly does grip strength improve with training?
›Does grip strength predict overall health?
›Is grip strength the same as overall muscle strength?
›Does testosterone therapy improve grip strength?
›How does menopause affect grip strength?
›What exercises are best for increasing grip strength?
›How many times per week should I train grip strength?
›Does protein intake affect grip strength gains from exercise?
›Can very old adults improve grip strength with training?
›How is grip strength measured correctly?
References
- Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62000-6/fulltext
- Tarp J, Støle AP, Blond K, Grøntved A. Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2019. https://www.bmj.com/content/372/bmj.n130
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://pubmed.ncbi.nlm.nih.gov/30312372/
- Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300-307. https://pubmed.ncbi.nlm.nih.gov/31836399/
- Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. J Clin Endocrinol Metab. 2011;96(9):2898-2903. https://academic.oup.com/jcem/article/96/9/2898/2834796
- Dodds RM, Syddall HE, Cooper R, et al. Global variation in grip strength: a systematic review and pooled analysis of 1.96 million participants. Lancet Glob Health. 2016. https://pubmed.ncbi.nlm.nih.gov/27254500/
- Leite LE, Resende TL, Nogueira GM, Cruz IBM, Schneider RH, Gottlieb MG. Effects of progressive exercise on grip strength in elderly. J Bodyw Mov Ther. 2018. https://pubmed.ncbi.nlm.nih.gov/30122336/
- López P, Pinto RS, Radaelli R, et al. Benefits of resistance training in physically frail elderly: a systematic review. Aging Clin Exp Res. 2018;30(8):889-899. https://pubmed.ncbi.nlm.nih.gov/29474608/
- Bohannon RW. Grip strength: an indispensable biomarker for older adults. Clin Interv Aging. 2019;14:1681-1691. https://pubmed.ncbi.nlm.nih.gov/31646562/
- Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci. 2002;57(10):B359-B365. https://pubmed.ncbi.nlm.nih.gov/11867659/
- Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281(6):558-560. https://pubmed.ncbi.nlm.nih.gov/10022113/
- Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005;60(3):324-333. https://pubmed.ncbi.nlm.nih.gov/15955710/
- Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25):1769-1775. https://www.nejm.org/doi/10.1056/NEJM199406233302501
- Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife. J Clin Endocrinol Metab. 2007. https://pubmed.ncbi.nlm.nih.gov/15955714/
- Greising SM, Baltgalvis KA, Lowe DA, Warren GL. Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2009;64(10):1071-1081. https://pubmed.ncbi.nlm.nih.gov/19543026/
- O'Neill TW, Pye SR, Fall CH, et al. Grip strength decline and its determinants in older European men. Eur J Endocrinol. 2011;165(2):225-234. https://pubmed.ncbi.nlm.nih.gov/21389097/
- Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1-7. https://www.nejm.org/doi/10.1056/NEJM199607043350101
- Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. https://pubmed.ncbi.nlm.nih.gov/28698222/
- Houston DK, Nicklas BJ, Ding J, et al. Dietary protein intake is associated with lean mass change in